These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17948903)

  • 1. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 is a bone-active cytokine.
    Yang J; Shah R; Robling AG; Templeton E; Yang H; Tracey KJ; Bidwell JP
    J Cell Physiol; 2008 Mar; 214(3):730-9. PubMed ID: 17786958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the role of osteocytes in the initiation of targeted remodeling.
    Heino TJ; Kurata K; Higaki H; Väänänen HK
    Technol Health Care; 2009; 17(1):49-56. PubMed ID: 19478405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow cell differentiation induced by mechanically damaged osteocytes in 3D gel-embedded culture.
    Kurata K; Heino TJ; Higaki H; Väänänen HK
    J Bone Miner Res; 2006 Apr; 21(4):616-25. PubMed ID: 16598382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
    Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
    J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
    Plotkin LI; Manolagas SC; Bellido T
    Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
    Bianchi ME; Manfredi AA
    Immunol Rev; 2007 Dec; 220():35-46. PubMed ID: 17979838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocytes: a proposed multifunctional bone cell.
    Bonewald LF
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):239-41. PubMed ID: 15758443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
    Sun NK; Chao CC
    Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of apoptosis of bone cells in vitro.
    Bellido T; Plotkin LI
    Methods Mol Biol; 2008; 455():51-75. PubMed ID: 18463810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 expression and release by bone cells.
    Charoonpatrapong K; Shah R; Robling AG; Alvarez M; Clapp DW; Chen S; Kopp RP; Pavalko FM; Yu J; Bidwell JP
    J Cell Physiol; 2006 May; 207(2):480-90. PubMed ID: 16419037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H; Andersson U
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC; Kaya Z; Katus HA; Andrassy M
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.